Latest filing published 11 Sept 2026 for Teladoc Health, Inc., €94k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Divita Charles III in Teladoc Health, Inc. We count 3 filings; the first trade dates from 2 June 2026 and the latest from 11 September 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 11 September 2026 came the latest disclosure, a transaction for €94k in Teladoc Health, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations